AIR. ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONS A controlled randomized, open label, multicenter, non-inferiority trial evaluating an individualized antibiotic treatment duration based on patient clinical response, evaluated through connected devices, for suspected community acquired pneumonia in the community setting

Community acquired pneumonia (CAP)

Percentage of cure at Day 15 after the start of treatment

Percentage of cure at Day 30, Duration of antibiotic treatment, Frequency and severity of adverse events between the 2 study arms, Patients' evolution of pneumonia symptoms and quality of life between the 2 study arms, A composite endpoint defined by the observation of one of the events characterizing the response to antibiotic treatment, among: clinical failure or; microbiological failure or; emergence of antibiotic resistance, Time to clinical recovery (regardless of microbiological recovery or resistance failure), Presence or absence of antimicrobial resistance at any point during follow-up, Association between specific antibiotics and respiratory microbiome evolution, Association between specific antibiotics and gut microbiome evolution, Duration of antimicrobial treatment

No related papers found yet.

Papers published before 2008-02-04 may not appear yet. Historical indexing is in progress.

France